Table 2.
Prediction of changes in CTX and P1NP using a general linear model
| Variables | CTX, pg/ml (330.759 ± 166.5) | P1NP, pg/ml (160.703 ± 139.9) | ||
|---|---|---|---|---|
| P-valuea | Partial Eta squared | P-valuea | Partial Eta squared | |
| EPO | < 0.0001 | 0.152 | 0.024 | 0.064 |
| Estrogen or testosterone | 0.029 | 0.060 | 0.816 | 0.001 |
| OPG | 0.335 | 0.012 | 0.009 | 0.083 |
| RANKL | 0.017 | 0.071 | < 0.0001 | 0.194 |
CTX carboxy terminal collagen cross links, P1NP N-terminal propeptide of type 1 collagen, EPO erythropoietin, OPG osteoprotegerin, RANKL receptor activator of NF-kappaB ligand
aP-values were calculated by a general linear model with CTX and P1NP as outcome variables